Trialsgram
beta
RCTs are beautiful
⚄
★
0
EN
⚙
View
Cystic fibrosis
1 trial
2019
ELX/TEZ/IVA
CFTR modulator
In
403 patients ≥12 years with CF carrying one F508del and one minimal-function mutation
,
elexacaftor-tezacaftor-ivacaftor
improved
ppFEV1 and exacerbation rate
compared with
placebo
.